Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Interferon alfa-2b offers protection from eye involvement in Behcet's disease

April 13, 2000

New ocular antibiotic enters the pipeline at InSite Vision

April 12, 2000

Gilead licenses NX-1838, a new AMD treatment, to EyeTech

April 10, 2000

QLT and Ciba Vision report positive Visudyne clinical results

April 3, 2000

Neurocrine Biosciences awarded NIH grant for retinal ischemia research

April 3, 2000

Visudyne T-IND program expanded

March 20, 2000

InSite Vision's batimastat eyedrops show antiangiogenic activity

March 20, 2000

Ciba Vision seeks approval of Rescula on two continents for treatment of glaucoma

March 14, 2000

Alocril now available in U.S. for itch associated with allergic conjunctivitis

March 2, 2000

Santen seeks FDA approval of levofloxacin for bacterial conjunctivitis

March 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...